HAEMONETICS CORP/MASS (HAE) Institutional Ownership and Insiders Activity

HAEMONETICS CORP/MASS (HAE) is widely held by institutional investors, with 331 firms reporting positions valued at approximately $3.72B based on SEC Form 13F filings for the quarter ended June 30, 2026.

Blackrock, Inc. is the largest disclosed holder, reporting approximately $443.19M in HAE holdings in its latest filing.

Recent insider activity includes 1 tracked Form 4 transaction over the last three months, reflecting ongoing executive and director trading activity.